A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
Clinical trial NCT04703322 · COMPLETED
Trial details
- NCT number
- NCT04703322
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-15
- Primary completion
- 2023-03-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.